Illustrating an additional AD-relevant mechanism of action, simufilam also disrupts an aberrant linkage of FLNA with TLR4, which again is induced by soluble Aβ42 binding, in this case to TLR4’s co-receptor CD14 [8,9,10]. Here, TLR4 is linked to Alzheimer disease.